Transcept Pharmaceuticals, Inc. (NASDAQ:TSPT) Stock Quotes and News

Transcept Pharmaceuticals, Inc. (TSPT) 3.09 0.06

Price Open:	2.96	Day's Range:	0.00000 - 6.75000
Price Close:	3.02	52wk Range:	0.00000 - 12.99
Price Day Change:	0.06	Volume:	179,783
Price % Change:	1.99	Market Cap:	57.8M
Bid:	1.50000	PE Ratio:	0
Ask:	3.09000	EPS Diluted:	-0.95

Trade TSPT NOW!

The Latest On TSPT

Benzinga's Top Downgrades 5/10/13 7:03am

Transcept Comments on New FDA Dosage Reduction Requirements for Zolpidem-Based Prescription Sleep Aids 1/10/13 10:46pm

UPDATE: Piper Jaffray Initiates Transcept Pharmaceuticals at Overweight on Sleep Aid Potential 1/4/13 1:29pm

Transcept Pharmaceuticals Announces Phase 2 Clinical Trial of TO-2061 for OCD Did Not Meet Primary Endpoint 12/21/12 8:33am

Transcept Pharmaceuticals Completes Patient Enrollment in Phase 2 Clinical Trial of OCD Drug 9/12/12 7:52am

Transcept Pharmaceuticals Announces Listing of New U.S. Patent for Intermezzo in FDA's Orange Book 8/21/12 4:42pm

Earnings Scheduled For August 13, 2012 8/13/12 12:26am

Transcept Pharmaceuticals Discusses Issuance of Patent in 8-K 7/5/12 5:42pm

Transcept Pharmaceuticals Appoints Leone Patterson as Vice President and Chief Financial Officer 6/26/12 4:02pm

Transcept Prices Public Offering of 4.5M Shares at $9.00 4/26/12 8:03am

Transcept Announces Proposed Public Offering 4/25/12 4:02pm

Morning Social Media Outlook for Monday April 10 (SFLY, VPHM, TSPT, MOH) 4/10/12 10:03am

Press Releases

Transcept Pharmaceuticals Reports First Quarter 2013 Financial Results 5/8/13 Newswire

Transcept Pharmaceuticals to Report First Quarter 2013 Financial Results and Host Conference Call on May 8, 2013 5/1/13 Newswire

Thomas J. Dietz, Ph.D., Appointed To The Transcept Pharmaceuticals Board Of Directors 4/10/13 Newswire

Transcept Pharmaceuticals to Present at Cowen and Company Health Care Conference on March 6 2/28/13 Newswire

Transcept Pharmaceuticals Reports Fourth Quarter And Full Year 2012 Financial Results 2/27/13 Newswire

Transcept Pharmaceuticals to Report Fourth Quarter and Full Year 2012 Financial Results and Host Conference Call on February 27, 2013 2/21/13 Newswire

Transcept Pharmaceuticals to Present at Two Upcoming Investor Conferences 2/5/13 Newswire

Transcept Pharmaceuticals Comments on New FDA Dosage Reduction Requirements for Zolpidem Based Prescription Sleep Aids Administered at Bedtime 1/10/13 Newswire

Transcept Pharmaceuticals Announces that a Phase 2 Clinical Trial of TO-2061 as Adjunctive Therapy for Obsessive Compulsive Disorder Did Not Meet Primary Endpoint 12/21/12 Newswire

Transcept Pharmaceuticals to Host Conference Call to Discuss Broadened Intermezzo® Commercialization Strategy and New Consumer Advertising Campaign by Purdue Pharma 11/26/12 Newswire

Transcept Pharmaceuticals Announces Broadened Intermezzo® Commercialization Strategy Including Initiation of a Direct to Consumer Advertising Campaign by Purdue Pharma 11/26/12 Newswire

Get the latest TSPT stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Transcept Pharmaceuticals, Inc. stock price.

Partner Headlines

Cheerleaders: Look Beyond Pharma For Jobs 5/16/13

Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog 5/8/13

Impax Beats Earnings Estimate - Analyst Blog 5/2/13

AMAG Narrows Loss; Maintains View - Analyst Blog 4/24/13

Merck - BMY in HCV Deal - Analyst Blog 4/23/13

Merck In-Licenses from Xenon - Analyst Blog 4/22/13

Sanofi's Vaccine Gets EU Approval - Analyst Blog 4/22/13

PSTI Plans to Start Phase I Study - Analyst Blog 4/19/13

Achillion's HCV Candidates Progress - Analyst Blog 4/17/13

Actelion Beats Earnings, Sales Rise - Analyst Blog 4/16/13

Repros Gets Additional Patents - Analyst Blog 4/12/13